Doping Journal Noteworthy Articles

Noteworthy section of the Doping Journal (ISSN 1812-948x) alerts interested readers about the selected noteworthy original research and viewpoint/review articles, book reviews, and meeting reports (published in other journals) on the subject of the Doping Journal scope.

DJ Home | Noteworthy home | DJ Content | Archiving your research in DJ is a new service by the Doping Journal DJ archive | Mission | PubMed | IFORA | Affiliates  | Contact us
We work for athletes, not corrupted antidoping officials, donate now to help us

November 6, 2007

The world anti-doping program and the primary care physician

Write to authors to ask them to make this article freely available at DJ archive. Learn more

Pediatr Clin North Am. 2007 Aug;54(4):701-11, x-xi
Hilderbrand RL
United States Anti-Doping Agency, 1330 Quail Lake Loop, Suite 260, Colorado Springs, CO 80906, USA


The presence of a prohibited substance in an athlete's urine (or blood, when applicable) or the use of a prohibited method constitutes a doping offense, even if the substance is a pharmaceutical and is properly prescribed. To avoid a doping offense for the therapeutic use of a prohibited substance or method the International Standard for Therapeutic Use Exemptions (TUE) must be followed. When the TUE is required, the appropriate process must be completed before testing under conditions where the substance or method is prohibited. This article describes the World Anti-Doping Code and the International Standards, which are part of the Code. In addition, the procedures for the proper preparation and submission of TUE requests are presented along with the manner in which the requests are considered by the Therapeutic Use Exemption Committees.

PubMed ID and Record

0 Comments:

Post a Comment

<< Home

DJ Home | Noteworthy home | DJ Content | Archiving your research in DJ is a new service by the Doping Journal DJ archive | Mission | PubMed | IFORA | Affiliates | Contact us